Brivaracetam: all 48 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal ConditionsEnrolling by invitationNCT06762743Phase 1
• Epileptic Hippocampus in Alzheimer's DiseaseNot yet recruitingNCT05899764Phase 1/2
• A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With SeizuresRecruitingNCT04715646Phase 3
• A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study ParticipantsCompletedNCT06312566Phase 1Results posted
• Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialCompletedNCT05639946Phase 3Results posted
• A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study ParticipantsCompletedNCT05315947Phase 1Results posted
• A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyCompletedNCT05109234Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese SubjectsCompletedNCT04882540Phase 1Results posted
• Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord InjuryCompletedNCT04379011Phase 1/2Results posted
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With EpilepsyCompletedNCT03405714Phase 2Results posted
• A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic SeizuresTerminatedNCT03325439Phase 3Results posted
• A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary GeneralizationCompletedNCT03250377Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With EpilepsyCompletedNCT03083665Phase 3Results posted
• A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit SettingCompletedNCT03021018Phase 2Results posted
• Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic SeizuresTerminatedNCT02088957Phase 2Results posted
• Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With EpilepsyCompletedNCT01728077Phase 3Results posted
• Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)CompletedNCT01653262Phase 3Results posted
• Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic TherapyCompletedNCT01405508Phase 3Results posted
• Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With EpilepsyCompletedNCT01364597Phase 3Results posted
• Brivaracetam Safety and Efficacy Follow-up Study in Subjects With EpilepsyCompletedNCT01339559Phase 3Results posted
• Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresCompletedNCT01261325Phase 3Results posted
• An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of BrivaracetamCompletedNCT00761774Phase 3Results posted
• A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresTerminatedNCT00699283Phase 3Results posted
• A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresTerminatedNCT00698581Phase 3Results posted
• Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From EpilepsyCompletedNCT00504881Phase 3Results posted
• Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresCompletedNCT00490035Phase 3Results posted
• Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresCompletedNCT00464269Phase 3Results posted
• Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.CompletedNCT00422422Phase 2Results posted
• Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and AdultsCompletedNCT00368251Phase 3Results posted
• Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From EpilepsyCompletedNCT00175916Phase 3Results posted
• A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.CompletedNCT00175825Phase 2Results posted
• A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)CompletedNCT00160667Phase 2Results posted
• This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam TreatmentCompletedNCT00150800Phase 3Results posted
• Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal EpilepsyCompletedNCT07563634Phase 3
• Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in EpilepsyCompletedNCT07163585Not applicable
• Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status EpilepticusCompletedNCT07163572Not applicable
• A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence EpilepsyActive, not recruitingNCT06315322Phase 3
• An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.Status unknownNCT05622370Phase 1
• Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse GliomasTerminatedNCT05029960Early Phase 1
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyCompletedNCT04666610Phase 3
• A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary GeneralizationCompletedNCT03685630Phase 3
• A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy VolunteersCompletedNCT02602860Phase 1
• A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male SubjectsCompletedNCT01710670Phase 1
• Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: BrivaracetamCompletedNCT00736931Phase 1
• An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.CompletedNCT00426673Phase 1
• Effect of Brivaracetam in Photosensitive Epileptic SubjectsCompletedNCT00401648Phase 2
• Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and AdultsCompletedNCT00357669Phase 3
• A Study of Brivaracetam in Subjects With Partial Onset SeizuresCompletedNCT00175929Phase 2

← Brivaracetam overview